Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Vaxjo – page 2

23 clinical trials in Vaxjo, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Vaxjo at a glance
23
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

23 trials in Vaxjo

Open in trial search

Tonsillitis

Recruiting

Study on Phenoxymethylpenicillin for Patients with Severe Streptococcus Group A-Negative Acute Tonsillitis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benzathine Benzylpenicillin
  • Sponsor:Region Joenkoepings Laen

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

HER2 positive breast cancer

Recruiting

Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karolinska University Hospital

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Bladder transitional cell carcinoma

Not recruiting

Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Region Skane

Type 2 diabetes mellitus

Not recruiting

Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Uppsala University

Hypercholesterolaemia

Not recruiting

Study on Evolocumab for Reducing Cardiovascular Events in Patients with Acute Myocardial Infarction

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Breast cancer

Not recruiting

Study of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Adenocarcinoma gastric+1

Not recruiting

Study on Irinotecan, Fluorouracil, Oxaliplatin, and Calcium Folinate for Patients with Resectable Stomach and Gastroesophageal Junction Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Region Skane

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Vaxjo

What the registry says about research in the country

01 Oncology Studies

Research focusing on innovative treatments for various cancers, including breast cancer, prostate cancer, and melanoma. Studies explore both early-stage and metastatic disease management.

  • Triple-negative breast cancer treatment optimization
  • Immunotherapy duration in melanoma
  • Biomarker-driven prostate cancer therapies

These trials aim to improve treatment outcomes and patient survival rates through targeted therapies and optimized treatment durations.

02 Cardiovascular & Metabolic Research

Studies addressing type 2 diabetes, dyslipidemia, and related conditions. Research includes innovative treatment approaches and comparative effectiveness studies.

  • Diabetes management optimization
  • Acute myocardial infarction treatments
  • Diabetic foot ulcer healing

Investigations focus on improving patient outcomes through novel therapeutic approaches and treatment combinations.

03 Women's Health Initiatives

Comprehensive research in HPV prevention and screening, along with studies in labor induction and women's reproductive health management.

  • Cervical cancer prevention strategies
  • Outpatient labor induction safety
  • HPV vaccination effectiveness

These trials aim to enhance preventive care and improve treatment protocols in women's health.

04 Renal & Urological Studies

Investigations into chronic kidney disease treatments and various urological conditions, including innovative surgical approaches.

  • CKD management strategies
  • Bladder cancer treatments
  • Surgical pain management protocols

Research focuses on improving treatment outcomes and patient quality of life in renal and urological conditions.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.